Hypertriglyceridemia
213
15
23
147
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
45 trials with published results (21%)
Research Maturity
147 completed trials (69% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.6%
14 terminated out of 213 trials
91.3%
+4.7% vs benchmark
30%
64 trials in Phase 3/4
31%
45 of 147 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 147 completed trials
Clinical Trials (213)
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
A Phase 2 Study to Evaluate the Efficacy and Safety of DR10624 in Subjects With Moderate Hypertriglyceridemia and Diabetic Kidney Disease
Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia
Standardized Large Yellow Tea Extract for Glucose and Lipid Metabolism in Overweight Adults With Hypertriglyceridemia
Effects of DHA-NAT on Postprandial Lipidaemia in Healthy Male Subjects
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
A Study to Assess the Safety, Tolerability and Efficacy of ION775
Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
RBD5044 in Chinese Participants With Hypertriglyceridemia
Nutritional Transitions to More Plant Proteins and Less Animal Proteins: Understanding the Induced Metabolic Reorientations and Searching for Their Biomarkers (ProVegOmics)
Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
A Phase III Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia
A Trial to Evaluate the Efficacy and Safety of DR10624 in Patients With Hypertriglyceridemia and Carotid Atherosclerotic Plaque
A Study of SHR-1918 In Participants With Hypertriglyceridemia
GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis
WB-EMS Effects on Cardiometabolic Risk Factors
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia
Effect of Consuming n-3 Polyunsaturated Fatty Acids Rich Foods on Triglyceride Concentration and Lipoprotein Composition
Russian Extreme Hypertriglyceridemia Registry
Single-ascending Dose Study of Kylo-12 in Healthy Subjects